Brainstorm Health

Page 17 of 38

FDA Drug Approvals 2019
Newsletters

The FDA Kept Up Its Drug Approval Streak In 2019

By
January 7, 2020
Fortune editor-in-chief Clifton Leaf addressing a room of industry experts at the 2018 Fortune Brainstorm Health conference in Laguna Niguel, Calif.
Newsletters

Our 5th Annual Brainstorm Health Conference

By
January 6, 2020
Brainstorm Health 2020 Signoff
Newsletters

A Holiday Reflection and Temporary Farewell

By
December 20, 2019
Healthcare Ideas 2020s
Newsletters

The Ideas That Will Shape Health Care in the Next Decade

By
December 19, 2019
Big Pharma ROI
Newsletters

Big Pharma’s Return on Investment Plummets to a Dismal 10-Year Low

By
December 18, 2019
Multiple myeloma MMRF
Newsletters

GlaxoSmithKline Hopes to Take on Rivals With Rare Blood Cancer Drug

By
December 18, 2019
Vaping E-Cig Lung Respiratory Illness Study
Newsletters

A New Study Shows the Damage Just 3 Years of Vaping Could Do to Your Lungs

By
December 16, 2019
Duchenne Sarepta FDA
Newsletters

FDA Approves Sarepta Duchenne Drug in Stunning Reversal

By
December 14, 2019
Stephen Hahn FDA Commissioner Confirmed
Newsletters

Meet Stephen Hahn, the New FDA Commissioner

By
December 13, 2019
Home Depot Theft Opioid Crisis
Newsletters

Is Loneliness Driving the Opioid Epidemic?

By
December 11, 2019
Flu Season 2020
Newsletters

Flu Season Came Early. Here’s What You Should Do

By
December 9, 2019
CVS CEO Larry Merlo Aetna Deal Interview
Newsletters

CVS CEO on What’s Happened After Its Aetna Merger—and What Comes Next

By
December 6, 2019
Biogen Alzheimers Drug Data
Newsletters

The Broader Implications of Biogen’s Divisive Alzheimer’s Drug

By
December 5, 2019
U.S. Health Data Trust Deficit
Newsletters

5 Health Leaders on the Trust Deficit in U.S. Medicine

By
December 4, 2019
Astellas Gene Therapy Deal
Newsletters

The Gene Therapy Spree Rolls on With $3 Billion Astellas Deal

By
December 3, 2019

Most Popular